Found 0 matching trials
Bioequivalence Trial of Pyronaridine Artesunate To-be-marketed Tablet to the Clinical Trial Reference Tablet PHASE1 The primary objective of this study is to determine the bioequivalence of t...
Show More Location
Cross Research S.A., Phase I Unit
Learn More & Join Trial
Comparing Safety and Protective Efficacy of Vaccine Candidate PfSPZ-CVac and MVA ME-TRAP/ ChAd63 ME-TRAP in Adults PHASE1 This is a single centre, randomized, placebo-controlled phase 1/2 study com...
Show More Location
Multiple Locations
Learn More & Join Trial
Pharmacokinetic Study of Primaquine and Pyronaridine-Artesunate in Healthy Subjects PHASE1 The observed changes of P. falciparum sensitivity to artemisinin lead to th...
Show More Location
Hospital of Tropical Diseases, Faculty of Tropical Medicine, Mahidol University
Learn More & Join Trial
Cohort Event Monitoring Study of Pyramax® PHASE4 The study is to be performed in public health facilities in Central and Wes...
Show More Location
The Biotechnology Center Nkolbisson, Univ of Yaounde I, Messa
Learn More & Join Trial
Pyronaridine Artesunate (3:1) in Children and Adults With Acute Plasmodium Vivax Malaria PHASE3 The purpose of this study is to compare the efficacy and safety of the fixe...
Show More Location
Pailin Referral Hospital
Learn More & Join Trial
Efficacy and Safety of Pyronaridine-Artesunate Versus Artemether-Lumefantrine PHASE2 In Nigeria, malaria is the commonest reason for outpatient clinic attendanc...
Show More Location
Ikeoluwapo O Ajayi
Learn More & Join Trial
Efficacy, Safety, and PK of M5717 in Combination With Pyronaridine as Chemoprevention in Adults and Adolescents With Asymptomatic Plasmodium Falciparum Infection (CAPTURE-2) PHASE2 This study evaluates the efficacy and safety of a single dose of M5717 plus...
Show More Location
Groupe de Recherche Action en Sante (GRAS)
Learn More & Join Trial
Four Different Experimental Drug Regimens to Standard of Care for the Treatment of Symptomatic Outpatients With COVID-19 PHASE2 This exploratory study is a randomized, single center, open label study of ...
Show More Location
Ezintsha, Wits Reproductive Health & HIV Institute University of the Witwatersrand
Learn More & Join Trial
Targeting High Risk Populations With Enhanced Reactive Focal Mass Drug Administration in Thailand NA This study assesses the effectiveness of reactive focal mass drug administr...
Show More Location
Division of Vector Born Diseases, Ministry of Health
Learn More & Join Trial
Feasibility, Acceptability and Costs of a Multiple First-lines Artemisinin-based Combination Therapies N/A A simultaneous deployment of multiple first line therapies (MFT) for uncomp...
Show More Location
Groupe de Recherche Action en Santé
Learn More & Join Trial